MicrobiologybioRxiv
Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2
S. B. Biering, E. Van Dis, E. Wehri…·S. A. Stanley
This study screens FDA-approved compounds for antiviral activity against SARS-CoV-2 and identifies 13 effective compounds, including seven new candidates and one synergistic combination with remdesivir.
DOI 10.1021/acsinfecdis.1c00017